Rethinking Alzheimer’s: A multi-target battle plan
TL;DR Summary
Alzheimer’s is viewed as a complex system driven by amyloid-beta and tau, aging, and systemic health; single-target drugs have limited impact, so researchers are pushing integrated, multi-pronged therapies—combining approaches like gene editing, senolytics, metabolic interventions, and gut-brain axis strategies—guided by early biomarkers and advanced models to slow, halt, or prevent disease progression.
Topics:health#aging#alzheimers-disease#gene-therapy#gut-brain-axis#health-and-medicine#multi-target-therapy
- Scientists say we’ve been treating Alzheimer’s all wrong ScienceDaily
- A New Era for Alzheimer’s Treatment: Promise, Tradeoffs, and Tough Questions National Academy of Medicine
- Six surprisingly hopeful advances in the battle against dementia The Telegraph
- Dementia breakthroughs in diagnosis, treatment and prevention WHYY
- Dementia Breakthroughs Shift Care For Philadelphia Families Hoodline
Reading Insights
Total Reads
0
Unique Readers
3
Time Saved
5 min
vs 6 min read
Condensed
95%
1,142 → 52 words
Want the full story? Read the original article
Read on ScienceDaily